376 related articles for article (PubMed ID: 25768247)
1. Highlights From the 2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)-European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
Costello FE; Santos-Lang M
J Neuroophthalmol; 2015 Jun; 35(2):e15-6. PubMed ID: 25768247
[No Abstract] [Full Text] [Related]
2. Multiple sclerosis update: hot topics from 5th joint triennial congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS).
Vogel D; van der Star B; Amor S
CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):99-100. PubMed ID: 22483288
[No Abstract] [Full Text] [Related]
3. European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS) - 7th Joint Triennial Congress (October 25-28, 2017 - Paris, France).
Díaz N
Drugs Today (Barc); 2017 Oct; 53(10):559-563. PubMed ID: 29286058
[TBL] [Abstract][Full Text] [Related]
4. Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Fernández Ó; Álvarez-Cermeño JC; Arroyo-González R; Brieva L; Calles-Hernández MC; Casanova-Estruch B; Comabella M; de las Heras V; García-Merino JA; Hernández-Pérez MA; Izquierdo G; Meca-Lallana JE; Muñoz-García D; Olascoaga J; Oreja-Guevara C; Prieto JM; Ramió-Torrentà L; Rodríguez-Antigüedad A; Romero-Pinel L; Sanchez F; Téllez N; Tintoré M; Montalban X;
Rev Neurol; 2012 Jun; 54(11):677-91. PubMed ID: 22627749
[TBL] [Abstract][Full Text] [Related]
5. 15th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 4th annual meeting of America's Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS). Basel, Switzerland, September 15-18, 1999. Joint RIMS-CMSC Symposium, Basel, Switzerland, September 14-16, 1999. Abstracts.
Mult Scler; 1999 Sep; 5 Suppl 1():S1-145. PubMed ID: 10597325
[No Abstract] [Full Text] [Related]
6. Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Fernandez O; Alvarez-Cermeno JC; Arroyo-Gonzalez R; Brieva L; Calles-Hernandez MC; Casanova-Estruch B; Comabella M; de las Heras V; Garcia-Merino JA; Hernandez-Perez MA; Izquierdo G; Meca-Lallana JE; Munoz-Garcia D; Olascoaga J; Oreja-Guevara C; Prieto JM; Ramio-Torrenta L; Rodriguez-Antiguedad A; Romero-Pinel L; Sanchez F; Tellez N; Tintore M; Montalban X;
Rev Neurol; 2012 Jun; 54(12):734-49. PubMed ID: 22673950
[TBL] [Abstract][Full Text] [Related]
7. ACTRIMS-ECTRIMS 2002. Abstracts of the 7th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis and 18th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. September 18-21, 2002. Baltimore, Maryland, USA.
Mult Scler; 2002 Sep; 8 Suppl 1():S1-142. PubMed ID: 12371412
[No Abstract] [Full Text] [Related]
8. Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019).
Lünemann JD; Diaz-Diaz J; Stankoff B; Young C; Siva A; Miller A; Lubetzki C; Wiendl H; Oreja-Guevara C
Mult Scler; 2020 Jun; 26(7):859-868. PubMed ID: 32364431
[TBL] [Abstract][Full Text] [Related]
9. The World Congress on Treatment and Research in Multiple Sclerosis (joint meeting of ECTRIMS, ACTRIMS, LACTRIMS).
Clanet M
Int MS J; 2009 Apr; 16(1):31-2. PubMed ID: 19413924
[TBL] [Abstract][Full Text] [Related]
10. Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Fernández Ó; Álvarez-Cermeño JC; Arnal-García C; Arroyo-González R; Brieva L; Calles-Hernández MC; Casanova-Estruch B; Comabella M; García-Merino JA; Izquierdo G; Meca-Lallana JE; Mendibe-Bilbao Mdel M; Muñoz-García D; Olascoaga J; Oliva-Nacarino P; Oreja-Guevara C; Prieto J; Ramió-Torrentà L; Romero-Pinel L; Saiz A; Rodríguez-Antigüedad A;
Rev Neurol; 2014 Oct; 59(7):307-16. PubMed ID: 25245875
[TBL] [Abstract][Full Text] [Related]
11. [Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)].
Fernandez O; Alvarez-Cermeno JC; Arroyo R; Brieva L; Calles-Hernandez MC; Casanova-Estruch B; Comabella M; Garcia-Merino JA; Ginestal R; Izquierdo G; Meca-Lallana JE; Mendibe-Bilbao MM; Montalban X; Munoz-Garcia D; Olascoaga J; Oliva-Nacarino P; Oreja-Guevara C; Ramio-Torrenta L; Romero-Pinel L; Rodriguez-Antiguedad A; Saiz A; Tintore M; Grupo Post-Ectrims GP
Rev Neurol; 2015 Sep; 61(5):215-24. PubMed ID: 26308843
[TBL] [Abstract][Full Text] [Related]
12. A need for national registries and international collaborative research in multiple sclerosis.
Myhr KM; Grytten N; Torkildsen Ø; Wergeland S; Bø L; Pugliatti M; Aarseth JH
Acta Neurol Scand Suppl; 2012; (195):1-3. PubMed ID: 23278648
[TBL] [Abstract][Full Text] [Related]
13. Meeting Report: 10 Years of Progress: Report from Selected Presentations at the 19th ECTRIMS Congress, 1720 September 2003, Milan, Italy.
Bates D
Int MS J; 2003 Dec; 10(4):121. PubMed ID: 14977488
[TBL] [Abstract][Full Text] [Related]
14. ECTRIMS 2000. 16th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. Toulouse, France. September 6-9, 2000. Abstracts.
Rev Neurol (Paris); 2000; 156 Suppl 3():3S10-200. PubMed ID: 11084703
[No Abstract] [Full Text] [Related]
15. ECTRIMS/ACTRIMS 2017: Closing in on neurorepair in progressive multiple sclerosis.
Kremer D; Küry P; Hartung HP
Mult Scler; 2018 May; 24(6):696-700. PubMed ID: 29629605
[TBL] [Abstract][Full Text] [Related]
16. Highlights from the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
Rabasseda X
Drugs Today (Barc); 2010 Jan; 46(1):49-67. PubMed ID: 20200696
[TBL] [Abstract][Full Text] [Related]
17. Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS). Basic and clinical issues in multiple sclerosis research. 18 October 1998, Montreal, Quebec, Canada. Proceedings.
Mult Scler; 1998 Dec; 4(6):497-522. PubMed ID: 10206731
[No Abstract] [Full Text] [Related]
18. 13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (II).
Fernández O; Montalban X; Aladro Y; Alonso A; Arroyo R; Calles C; Castillo-Triviño T; Comabella M; Costa-Frossard L; Forero L; Ginestal R; Landete L; Llaneza M; Llufriu S; Martínez-Ginés ML; Meca-Lallana J; Mendibe M; Oreja-Guevara C; Oterino A; Prieto JM; Ramió-Torrentà L; Romero-Pinel L; Téllez N; Rodríguez-Antigüedad A
Rev Neurol; 2021 Jun; 72(12):433-442. PubMed ID: 34109999
[TBL] [Abstract][Full Text] [Related]
19. Ethical use of off-label disease-modifying therapies for multiple sclerosis.
Laurson-Doube J; Rijke N; Helme A; Baneke P; Banwell B; Viswanathan S; Hemmer B; Yamout B
Mult Scler; 2021 Aug; 27(9):1403-1410. PubMed ID: 34304636
[TBL] [Abstract][Full Text] [Related]
20. Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Fernandez O; Arnal-Garcia C; Arroyo-Gonzalez R; Brieva L; Calles-Hernandez MC; Casanova-Estruch B; Comabella M; de Las Heras V; Garcia-Merino JA; Hernandez-Perez MA; Izquierdo G; Matas E; Meca-Lallana JE; Mendibe-Bilbao MM; Munoz-Garcia D; Olascoaga J; Oreja-Guevara C; Prieto JM; Ramio-Torrenta L; Rodriguez-Antiguedad A; Saiz A; Tellez N; Villar LM; Tintore M; Grupo Post-Ectrims GP
Rev Neurol; 2013 Sep; 57(6):269-81. PubMed ID: 24008938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
